Clinical Trial Update: Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rifaximin to norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Liver Cirrhosis
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Norfloxacin (Norfloxacin)
• Rifaximin (rifaximin)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Spontaneous Bacterial Peritonitis, Ascites | Phase 3 | Status: UNKNOWN